KPTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Karyopharm Therapeutics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.35−0.04 (-11.30%)
Close on Oct 19, 2026
- Market cap
- $10.01K
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Karyopharm Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 22, 2026 | Oct 22, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 13, 2026 | Oct 14, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 17, 2026 | Sep 18, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 10, 2026 | Sep 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 31, 2026 | Aug 31, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2026 | Jul 31, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 13, 2026 | Jul 17, 2026 | SEC EDGAR |
| Current report | 8-K | May 21, 2026 | May 28, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 13, 2026 | Apr 13, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2026 | Mar 27, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2026 | Mar 24, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 27, 2026 | Mar 3, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2026 | Feb 19, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 13, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 12, 2026 | Feb 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Feb 18, 2026 | Jan 9, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 3, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 10, 2025 | Oct 14, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 7, 2025 | Oct 8, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 5, 2025 | Sep 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 11, 2025 | Jul 11, 2025 | SEC EDGAR |
| Current report | 8-K | May 28, 2025 | May 29, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 28, 2025 | Apr 14, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2025 | Feb 24, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 19, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 19, 2025 | Feb 19, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 27, 2025 | Jan 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 30, 2025 | Jan 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 2, 2025 | Jan 2, 2025 | SEC EDGAR |